# Preoperative Gabapentin vs Placebo for Vaginal Prolapse Surgery

> **NCT05658887** · PHASE4 · COMPLETED · sponsor: **Joseph Kowalski** · enrollment: 110 (actual)

## Conditions studied

- Pelvic Organ Prolapse
- Perioperative/Postoperative Complications

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Gabapentin Placebo

## Key facts

- **NCT ID:** NCT05658887
- **Lead sponsor:** Joseph Kowalski
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05658887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05658887, "Preoperative Gabapentin vs Placebo for Vaginal Prolapse Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05658887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*